Hair loss and scalp cooling with breast cancer chemotherapy

In the SCALP randomised trial (Nangia 2017, JAMA) 50.5% of women cooled during taxane, anthracycline or both kept more than half their hair after the fourth cycle against 0% of controls. In the DigniCap cohort (Rugo 2017), which excluded anthracycline regimens, 66.3% kept at least half their hair. Macmillan says hair loss usually starts after the first or second treatment, that eyebrows and eyelashes can go too, that a wig is best fitted before treatment starts, and that hair usually starts to grow back after treatment, sometimes different in texture or colour. This is orientation from public patient pages and guidelines, not advice for your case: your own team's instructions and 24-hour number come first.